İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 81
YÖKSİS81 OpenAlex0
Proje 1
Kitap 7
Bildiri 63

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 15
h-indeks 7 Türkiye yüzdelik dilimi: 77 Üniversitesinde h-indekse göre 47. / 649
i10-indeks
5
Toplam atıf
165
Türkiye’de üst %25
Makale başına
11,0
FWCI
0,80
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
1

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 71
  • Q1 25
  • Q2 13
  • Q3 14
  • Q4 19
WoS (JCR) 66
  • Q1 8
  • Q2 15
  • Q3 20
  • Q4 23
TR Index TR Index

20 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 1
  • Ort. 58.9%
  • n 16
Diğer sayımlar

Scopus (SJR)

  • Özet hariç 70 Q1 25 Q2 13 Q3 14 Q4 18
  • YÖKSİS satırı 73

WoS (JCR)

  • Özet hariç 65 Q1 8 Q2 15 Q3 20 Q4 22
  • YÖKSİS satırı 69

TR Index

  • Özet hariç 19 makale
  • YÖKSİS satırı 22 makale

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

60 dergi

Makale listesi

  1. 2025 Managing Candida auris fungemias: the results of a prospective and international study Antimicrobial Agents and Chemotherapy DOI 10.1128/aac.00358-25 YÖKSİS SJR Q1 JCR Q2
  2. 2025 Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission Turkish Journal of Internal Medicine DOI 10.46310/tjim.1502238 YÖKSİS
  3. 2024 Prevalence of Cardiovascular Disease and Comparison of Risk Category Predictions of Systemic Coronary Risk Evaluation Score-2 and 4 Other Cardiovascular Disease Risk Assessment Tools Among People Living with Human Immunodefficiency Virus in Türkiye The Anatolian Journal of Cardiology DOI 10.14744/AnatolJCardiol.2024.4558 YÖKSİS TR Index SJR Q3 JCR Q3
  4. 2024 Profiles of primary brain abscesses and their impact on survival: An international ID-IRI study International Journal of Infectious Diseases DOI 10.1016/j.ijid.2024.107228 YÖKSİS SJR Q1 JCR Q1
  5. 2024 Efficacy of favipiravir in COVID-19: A retrospective two center comparative study The Journal of Infection in Developing Countries DOI 10.3855/jidc.18039 YÖKSİS SJR Q3 JCR Q4
  6. 2024 Diagnostic performance between RT-PCR and chest CT in outpatients with clinically suspected COVID-19 Marmara Medical Journal DOI 10.5472/marumj.1379916 YÖKSİS TR Index SJR Q4
  7. 2024 Latent Tuberculosis Infection Management in Solid Organ Transplantation Recipients: A National Snapshot Thoracic research and practice DOI 10.5152/ThoracResPract.2024.23110 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 86.8%
  8. 2023 Factors Associated with 28-day Critical Illness Development During the First Wave of COVID-19 INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY DOI 10.36519/idcm.2023.206 YÖKSİS TR Index SJR Q4 JCR Q4
  9. 2023 Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial Clin Microbiol Infect. DOI 10.1016/j.cmi.2023.10.014 2 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.0%
  10. 2023 Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study Springer Science and Business Media LLC DOI 10.1007/s10096-023-04630-9 2 YÖKSİS kaydı YÖKSİS SJR Q1 JCR Q2 OpenAlex 78.8%
  11. 2023 The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey Journal of Infection in Developing Countries DOI 10.3855/jidc.18041 YÖKSİS SJR Q3 JCR Q4
  12. 2023 Nosocomial infection of C. auris in COVID-19 Intensive Care Unit in Türkiye and Phylogenetic Analysis of Isolates. Mycopathologia DOI 10.1007/s11046-023-00782-6 YÖKSİS SJR Q1 JCR Q2
  13. 2023 Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints INFECTIOSUS DISEASES DOI 10.1080/23744235.2023.2226709 YÖKSİS SJR Q1 JCR Q1 OpenAlex 74.0%
  14. 2023 Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study BMC Infectious Diseases DOI 10.1186/s12879-023-08596-z YÖKSİS SJR Q1 JCR Q2
  15. 2023 Nosocomial infection of C. auris in COVID-19 Intensive Care Unit in Turkiye and Phylogenetic Analysis of Isolates MYCOPATHOLOGIA DOI 10.1007/s11046-023-00782-6 YÖKSİS SJR Q1 JCR Q2
  16. 2023 Disseminated Nocardia farcinica infection and treatment response on F-18 fludeoxyglucose positron emission tomography computed tomography Indian J Nucl Med. DOI 10.4103/ijnm.ijnm_148_21 YÖKSİS SJR Q4 JCR Q4
  17. 2023 Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic Turkish Journal of Pharmaceutical Sciences DOI 10.4274/tjps.galenos.2023.47105 2 YÖKSİS kaydı YÖKSİS TR Index JCR Q3 OpenAlex 44.6%
  18. 2022 Comparison of Turkish version of the medical outcomes study-HIV health survey with short form health survey-36 in people living with human immunodeficiency virus The International Journal of Health Planning and Management DOI 10.1002/hpm.3450 YÖKSİS SJR Q2 JCR Q3
  19. 2022 Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting European Journal of Clinical Microbiology & Infectious Diseases DOI 10.1007/s10096-022-04425-4 YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.8%
  20. 2022 Topical cidofovir‐related acute kidney injury in a kidney transplant recipient Wiley DOI 10.1111/ctr.14824 YÖKSİS SJR Q1 JCR Q2

Akademisyenlere dön